ST PharmLtd Balance Sheet Health
Financial Health criteria checks 4/6
ST PharmLtd has a total shareholder equity of ₩386.9B and total debt of ₩188.9B, which brings its debt-to-equity ratio to 48.8%. Its total assets and total liabilities are ₩675.4B and ₩288.5B respectively. ST PharmLtd's EBIT is ₩33.5B making its interest coverage ratio 9.1. It has cash and short-term investments of ₩90.1B.
Key information
48.8%
Debt to equity ratio
₩188.90b
Debt
| Interest coverage ratio | 9.1x |
| Cash | ₩90.10b |
| Equity | ₩386.91b |
| Total liabilities | ₩288.53b |
| Total assets | ₩675.44b |
Recent financial health updates
Recent updates
Why ST PharmLtd's (KOSDAQ:237690) Earnings Are Better Than They Seem
Mar 22
ST Pharm Co.,Ltd. (KOSDAQ:237690) Stock Rockets 54% As Investors Are Less Pessimistic Than Expected
Mar 18Investors Who Bought ST PharmLtd (KOSDAQ:237690) Shares A Year Ago Are Now Up 221%
Mar 16Calculating The Fair Value Of ST Pharm Co.,Ltd. (KOSDAQ:237690)
Jan 22What Type Of Shareholders Own The Most Number of ST Pharm Co.,Ltd. (KOSDAQ:237690) Shares?
Dec 23Health Check: How Prudently Does ST PharmLtd (KOSDAQ:237690) Use Debt?
Nov 26
Financial Position Analysis
Short Term Liabilities: A237690's short term assets (₩348.4B) exceed its short term liabilities (₩83.7B).
Long Term Liabilities: A237690's short term assets (₩348.4B) exceed its long term liabilities (₩204.8B).
Debt to Equity History and Analysis
Debt Level: A237690's net debt to equity ratio (25.5%) is considered satisfactory.
Reducing Debt: A237690's debt to equity ratio has increased from 0.04% to 48.8% over the past 5 years.
Debt Coverage: A237690's debt is not well covered by operating cash flow (0.7%).
Interest Coverage: A237690's interest payments on its debt are well covered by EBIT (9.1x coverage).